Oppenheimer & Co’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-7,847	Closed	-$466K	–	1697
2025 Q4	$466K	Sell	7,847 -2,028	-21%	-$110K	0.01%	1101
2025 Q3	$535K	Buy	9,875 +728	+8%	+$41.6K	0.01%	1150
2025 Q2	$503K	Buy	9,147 +3,736	+69%	+$220K	0.01%	1149
2025 Q1	$383K	Buy	+5,411	New	+$364K	0.01%	1175
2024 Q2	–	Sell	-4,714	Closed	-$412K	–	1441
2024 Q1	$412K	Buy	4,714 +1,949	+70%	+$174K	0.01%	1063
2023 Q4	$267K	Buy	2,765 +71	+3%	+$6.28K	﹤0.01%	1188
2023 Q3	$238K	Sell	2,694 -602	-18%	-$53.6K	﹤0.01%	1211
2023 Q2	$286K	Buy	3,296 +369	+13%	+$34.7K	0.01%	1174
2023 Q1	$285K	Buy	+2,927	New	+$303K	0.01%	1140
2015 Q3	–	Sell	-11,831	Closed	-$1.62M	–	1361
2015 Q2	$1.62M	Buy	+11,831	New	+$1.47M	0.05%	475
2014 Q2	–	Sell	-3,214	Closed	-$219K	–	1415
2014 Q1	$219K	Sell	3,214 -2	-0.1%	-$147	0.01%	1193
2013 Q4	$226K	Buy	+3,216	New	+$218K	0.01%	1152